Amgen (AMGN) R&D In Process (2021)

Amgen has reported R&D In Process over the past 1 years, most recently at $1.5 billion for Q2 2021.

For Q2 2021, R&D In Process changed N/A year-over-year to $1.5 billion; the TTM value through Jun 2022 reached $1.5 billion, changed 0.0%, while the annual FY2021 figure was $1.5 billion, N/A changed from the prior year.
R&D In Process for Q2 2021 was $1.5 billion at Amgen.
Over five years, R&D In Process peaked at $1.5 billion in Q2 2021 and troughed at $1.5 billion in Q2 2021.

Peer Comparison